Back to Search
Start Over
Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients: A Multicenter, Open Label Phase 1/2 Study.
- Source :
- Clinical Lymphoma, Myeloma & Leukemia; Feb2017 Supplement, Vol. 17, pe59-e59, 1p
- Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 21522650
- Volume :
- 17
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma, Myeloma & Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 122646644
- Full Text :
- https://doi.org/10.1016/j.clml.2017.03.108